A Single-Blind, Randomized, Parallel Trial to Define the ECG Effects of Sancuso (Granisetron Transdermal System) Compared to Placebo and Moxifloxacin in Healthy Men and Women

Trial Profile

A Single-Blind, Randomized, Parallel Trial to Define the ECG Effects of Sancuso (Granisetron Transdermal System) Compared to Placebo and Moxifloxacin in Healthy Men and Women

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Mar 2012

At a glance

  • Drugs Granisetron; Granisetron; Moxifloxacin
  • Indications Bacterial infections; Chemotherapy-induced nausea and vomiting
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors ProStrakan
  • Most Recent Events

    • 08 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 08 Oct 2009 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
    • 18 Jun 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top